Tower Research Capital (TRC)’s IceCure Medical ICCM Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCM
Tower Research Capital (TRC)'s ICCM Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in IceCure Medical (ICCM) in Q3 2026: 297 shares worth $480. The stake represents ﹤0.01% of the portfolio and ranks #5555 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in ICCM as recently as Q4 2024.
Tower Research Capital (TRC) first reported a position in ICCM in Q3 2021 and has held it in 9 quarters since. The position peaked at $1K in Q3 2021. 12 funds tracked by Wall St. Rank hold ICCM as of Q3 2026.
- Tower Research Capital (TRC) held 297 shares of IceCure Medical worth $480 as of Q3 2026.
- IceCure Medical was a new Tower Research Capital (TRC) position in Q3 2026.
- IceCure Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5555 holding.
- Tower Research Capital (TRC) first reported a position in IceCure Medical in Q3 2021 and has held it in 9 quarters since.
- Tower Research Capital (TRC)'s IceCure Medical position peaked at $1K in Q3 2021.
- 12 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.